Micromethods for the assay of insulin based on the reaction between 131I-labelled insulin and insulin antibody have been described by Yalow & Berson (1960) and Grodsky & Forsham (1960) . In principle they depend on the use of insulin antibody to obtain samples of insulin from mixtures prepared by adding standard or unknown solutions of unlabelled insulin to a fixed amount of 131I-labelled insulin and thereby to compare the specific activities of the mixtures (which will diminish as the amount of unlabelled insulin increases). In principle, therefore, these methods depend on isotope dilution. Since most insulin-antibody complexes are soluble, it has been necessary to devise some method of separating free insulin from antibody-bound insulin. In the method of Yalow & Berson (1960) this was achieved by electrophoresis with solvent flow (chromatoelectrophoresis), whereas Grodsky & Forsham (1960) employed fractional precipitation with salts. The assay of insulin was achieved empirically by comparing the activities of standard and unknown solutions of the hormone.
In the methods described in the present paper, use has been made of the fact that insulin antibody or the complex it forms with insulin may be precipitated with anti-y-globulin serum, as first described by Skom & Talmage (1958) . In the method initially developed this precipitation reaction was used to separate the antibody-bound insulin from the free insulin. When it was found that insulin antibody that had been precipitated with anti-y-globulin serum was still capable of reacting with insulin, new assay methods were developed with pre-precipitated insulin antibody. The methods described in the present paper appear to have the advantages over those previously described of greater simplicity and rapidity, and of achieving comparable sensitivity with preparations of 131I-labelled insulin of much lower specific activity. Preliminary accounts of these methods have been published (Hales & Randle, 1962 , 1963 .
EXPERIMENTAL
Materials and methods Insulin. Ox insulin (recrystallized six times) and pig insulin were given by Boots Pure Drug Co. Ltd., Nottingham, by Burroughs Wellcome. Beckenham, Kent, and Eli Lilly and Co., Indianopolis, U.S.A. Human insulin was prepared from autopsy pancreas by an unpublished method of Dr L. F. Smith. Prepared in this way, it ran as a single band on ascending chromatography in butan-2-ol-aq. 1 % (v/v) acetic acid (1:1, v/v) (Fenton, 1959) . The potency of human insulin by rat-diaphragm bioassay (Randle, 1956) was indistinguishable from that of ox insulin [stated potency 22-3 i.u./mg. (95% confidence limits in the range 7-4-66-9 i.u./mg.)]. Standard solutions of insulin for immunoassay were prepared by diluting a stock solution of 0-2 mg./ml. (in 3-3 mM-HCl) with buffer [40 mM-sodium phosphate, pH 7 4, containing bovine plasma albumin (1 mg./ml.), merthiolate (0-6 mM) and NaCl (0.9%)].
13II-labelled insulin. containing Nal (0-4M) and NaIO3 (0-2M) was added dropwise with shaking (in a 10 ml. stoppered cylinder) 2-4 ml. of conc. HCI (until the black precipitate disappeared); 1 ml. Of CC14 and 1 drop of 0-IM-NaI were added together with water to give a total volume of 11 ml. This stock solution of ICI was kept at 40 and diluted for iodination (1 ml. of stock ICI solution added to 22-85 ml. of 2M-NaCl, 2-06 ml. of NNaOH and 22-84 ml. of water, and the whole diluted fourfold with 60 mm-glycine-0 1N-HCl-0-24M-NaCl). The purity of the preparation was checked by mixture with unlabelled insulin followed by ascending chromatography (Fenton, 1959) and by zone electrophoresis for 3 hr. at 300v on Whatman 3MM chromatography paper in barbitone buffer, pH 8-6 (Flynn & de Mayo, 1951) , containing urea (7M). Chromatograms and electrophoretograms were stained for protein with bromocresol green (Fenton, 1959) and radioautographs prepared on Ilford X-ray film (Industrial G). In most instances a single band of radioactivity was detected which was coincident with the band of protein staining. The specific activity (on assuming 100% recovery of insulin) was 5-20 mc/mg. Guinea-pig anti-insulin serum. Antisera to human, ox and pig insulins were prepared in guinea pigs by the method of Robinson & Wright (1961) .
Rabbit anti-(guinea-pig y-globulin) serum. Crude guineapig y-globulin was obtained from normal guinea-pig serum C. N. HALES ANTD P. J. RANDLE by precipitation with (NH4)2SO4 [1 vol. of sat. (NH4)2SO4 plus 2 vol. of serum] followed by dialysis against water and freeze-drying. For the production of antisera 10 mg. was dissolved in 1 ml. of 0-9% NaCl and emulsified with an equal volume of complete Freund's adjuvant. Weekly injections (subcutaneously into the back) were made into rabbits for 1 month, followed by weekly injections of 10 mg. of globulin in 1 ml. of 0 9% NaCl. After a total of 6 weeks the animals were bled by cardiac puncture. A precipitin test was carried out with 0-2 ml. of doubling dilutions of the antiserum and 0 1 ml. of a solution of crude guinea-pig y-globulin (1 mg./ml.) in 0-9% NaCl. A satisfactory antiserum gives a visible precipitate in this system at dilutions of 1:64 or more. Further blood samples were taken at weekly intervals, and after this an additional injection of y-globulin was given. Blood 8ample8. Rabbit and guinea-pig sera or antisera were separated by centrifuging from blood that had been allowed to clot for 16 hr. at 4°. Blood samples were obtained by cardiac puncture under ether anaesthesia. For assay of insulin, human blood was collected from an antecubital vein and rat blood was drawn from the inferior vena cava under Nembutal anaesthesia. Crystalline heparin (0-2 mg./ml.) (given by Evans Medical Ltd., Liverpool) was added to prevent coagulation, and plasma was separated by centrifuging (plasma was preferred to serum because haemolysis is less frequent and the latter interferes with the immunoassay of insulin Storage. Antisera were diluted with 0-04M-tris-HCl buffer or 0 04M-phosphate buffer, pH 7 4, containing bovine plasma albumin (1 mg./ml.) and merthiolate (0-6 mm), and stored at -100 in 5 ml. lots (or whatever was appropriate for a single experiment). This method of storage was necessary because repeated freezing and thawing leads to loss of potency. Solutions of human insulin in 3-3 mm-HCl stored at -100 lost activity slowly and it was advisable to limit storage to 1 month. It follows that CO/Ci will be linearly related to i, that CO/Ci will be unity when i is zero, that io = -i when CO/Ci is zero and that the slope of the line is l/io (see Fig. 1 ). The theoretical relationship given above will only hold in practice if the affinity of antibody for 1311-labelled insulin and unlabelled insulin is the same and if the amount of insulin bound by antibody is independent of the concentration of insulin. Departures from this theoretical relationship in practice will not, however, interfere with the practical assay of insulin provided that the latter is made by reference to standard solutions of the hormone.
Procedures for immunological assay of insulin Three procedures for the immunoassay of insulin have been developed and the choice of a particular procedure depends on the purpose for which it is required. In the first (method A) 1811-labelled insulin plus or minus standard or unknown solutions of unlabelled insulin is incubated with insulin antibody, and the insulin-antibody complex is subsequently precipitated with anti-y-globulin serum (precipitating antiserum), filtered and assayed for radioactivity. It is quicker than the other methods but less satisfactory for the assay of insulin in plasma because yglobulin may interfere with precipitation of the insulinantibody complex by cross-reacting with the precipitating antiserum (unless high concentrations of the latter are used). In the second (method B) the insulin antibody is first precipitated by incubation with precipitating antiserum, then incubated with "III-labelled insulin plus or minus standard or unknown solutions of unlabelled insulin and finally filtered and assayed for radioactivity. In the third (method C) the procedure is as for method B but the precipitated antibody is incubated with standard or unknown solutions of unlabelled insulin for a short period before the addition of 1311-labelled insulin. This modification of method B increases the sensitivity of the assay. Methods B and C are the methods of choice for assay of insulin in plasma because y-globulin in plasma is not introduced until after the precipitation of insulin antibody, and consequently cannot interfere by cross-reacting with the precipitating antiserum.
Practical detail8 Concentration of 13"I-labelled insulin. The concentration of 13LI-labelled insulin used represents a compromise between the need to have sufficient radioactivity for counting and the need for unlabelled insulin to form a reasonable proportion of the mixture. It is convenient to add 250 ,upg. of 131I-labelled insulin, which (at 12 mc/mg.) yields a final count of about 1000/min. in a Nuclear-Chicago gas-flow counter (efficiency approx. 30%) when no unlabelled insulin is added and which permits the detection of 250,uAtg. of human insulin/ml. (approx. 6 x 10-6 i.u./ml.).
Concentration of anti-insulin .serum. In method A, 0-1 ml. of 1311-labelled insulin solution [diluted to 2-5,mg./ ml. with 40 mM-phosphate buffer, pH 7-4, containing bovine plasma albumin (1 mg./ml.) and merthiolate (0-6 mm)], 0-1 ml. of 0-9% NaCl and 0-1 ml. of different dilutions of anti-insulin serum (doubling dilutions between 1:1000 and 1: 32 000 made with phosphate buffer containing albumin and merthiolate) were mixed in tubes (5 cm. x 1 cm.) and incubated at 40 for 4 hr. Precipitating antiserum (0-1 ml. of 1:2 to 1:16 dilutions was suitable, depending on the activity of a particular precipitating antiserum) was added and incubation continued for a further 18 hr. The precipitated insulin-antibody complex was then collected by filtration on 2 cm. Oxoid cellulose acetate membranes (Oxo Ltd., London) mounted on a Pyrex hydrosol microanalysis filter-holder (Millipore Filter Corp., Bedford, Mass.; catalogue no. XX 10 025 00, obtained through V. A. Howe and Co. Ltd.). The tubes were washed twice with 0-75 ml. of 4% (w/v) bovine plasma albumin in 40 mM-phosphate buffer, pH 7 4, with the aid of a Pasteur pipette and the washings filtered. The addition of albumin to the wash fluid prevented the retention of free 13II-labelled insulin by the cellulose acetate membranes (pig plasma clarified by filtration through kieselguhr provides a cheaper and apparently satisfactory alternative to bovine plasma albumin). The efficiency of the washing procedure was controlled by the inclusion of a tube in which insulin antiserum was replaced by phosphatealbumin-merthiolate solution. The membranes were then fixed on to unwaxed cardboard bottle-top liners by Dunlop rubber solution, dried for 1 hr. at 750 and assayed for radioactivity in a Nuclear-Chicago gas-flow counter (1000 counts being recorded). To check the recovery of radioactive insulin in the insulin-antibody precipitate, 0-1 ml. of 13l1-labelled insulin solution was plated and counted at the same time.
In methods B and C, 0-1 ml. of a mixture of equal volumes of dilutions of anti-insulin serum (see above) and of 1:15 precipitating antiserum was incubated at 40 for 16-24 hr. in tubes (5 cm. x 1 cm.). To each was then added 0-1 ml. of 1311-labelled insulin solution (containing 250pjug.) and 0-1 ml. of phosphate-albumin-merthiolate-NaCl, and after mixing incubation was continued for a further 22 hr. The contents of each tube were then filtered and the radioactivity was assayed as described above.
In each method the concentration of anti-insulin serum which removed approximately half the total radioactivity was selected for insulin assay.
Assay of insulin. In method A, 131I-labelled insulin (250,upg. in 0-1 ml.) was mixed with 0-1 ml. of standard or unknown solutions of insulin or phosphate-albuminmerthiolate-NaCl, and diluted antiserum (0-1 ml.) added with mixing. The subsequent procedure was as described in the preceding section. In method B, 0-1 ml. of 131I-labelled insulin (250ppg.) and 0-1 ml. of phosphatealbumin-merthiolate-NaCl or standard or unknown solutions of unlabelled insulin were added after 16-24 hr. of precipitation of the insulin antibody with precipitating antiserum; the procedure was otherwise as outlined in the preceding section. In method C, 0-1 ml. of phosphatealbumin-merthiolate-NaCl or standard or unknown solutions of unlabelled insuliln were added 16-24 hr. after the mixing of the insulin antibody with precipitating antiserum. The contents of the tubes were mixed and incubated for 6 hr. at 4°. The 1311-labelled insulin (250 jutg. in 0-1 ml.) was then added and, after mixing of the solutions, incubation was continued at 40 for a further 16 hr. The procedure was then as given in the preceding section. RESULTS Effect of different experimental conditions on recovery of 1311-labelled insulin. The effect of the concentration of anti-insulin serum on the recovery of 131I-labelled insulin in a typical experiment is shown in Fig. 2 . The results shown were obtained with method A but essentially similar results are obtained with methods B and C. With antiserum in excess (usually at dilutions between 1:1000 and 1: 4000) 90-96 % of the radioactivity was recovered in the precipitate in each experiment, from which it is concluded that precipitation of the insulin-antibody complex by anti-y-globulin serum is substantially complete. With further dilution of the anti-insulin serum there was a diminution in the fraction of 131I-labelled insulin recovered in the precipitate. Satisfactory recovery of radioactivity in the precipitate has been achieved in all methods without the addition of further (carrier) guinea-pig y-globulin, and indeed the latter did not improve the recovery of radioactivity.
The effect of different concentrations of rabbit it has been found that removal of 131I-labelled inti-(guinea-pig y-globulin) serum on the removal insulin is diminished when undiluted precipitating f 131I-labelled insulin at different concentrations antiserum is used. It is suggested that this is due )f anti-insulin serum in method A is shown in to the action of unlabelled insulin in the precipi- Fig. 3 (Fig. 4) . Fig. 2 . Effect of the concentration of antiserum on the Hence it seemed advisable in method A to wait for recovery of 13II-labelled insulin. Experimental details are at least 1 hr. before adding precipitating antiserum, given in the text.
and for convenience a period of 4 hr. has been used as a routine followed by 18 hr. of precipitation.
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In the development of method A, it was found that at least 14 hr. is needed for precipitation of the insulin complexed with antibody by anti-y-globulin serum as judged by the recovery of radioactivity under assay conditions (i.e. with insulin in excess of antibody). In developing methods B and C, therefore, 16-24 hr. of incubation was allowed for precipitation. Longer periods of incubation are unsuitable since less insulin is bound by antibody when 36 or 48 hr. of precipitation is used. Aggregation of the precipitate into larger particles with longer periods of precipitation may explain the decreased recovery of insulin observed. The effect of the period of incubation of precipitated insulin antibody with 131-labelled insulin on the recovery of the latter in the precipitate in methods B and C is shown in Fig. 5 . The removal of insulin was substantially complete at 24 hr. In practice it has been convenient to use a period of 22 hr.
Effect of different concentrations of unlabelled insulin on the recovery of 131I-labelled insulin. The effect of increasing concentration of human, ox and pig insulins on the recovery of 13I-labelled ox insulin bound by guinea-pig anti-(human insulin) serum in method A is shown in Fig. 6 . The curve is in the general form obtained in their methods by Yalow & Berson (1960) and Grodsky & Forsham (1960) . With this particular antiserum there was little difference between the curves obtained with human, ox or pig insulins. We do not know whether the lack of discrimination between these different insulins is a general property of antisera to human insulin. With antisera to ox and pig insulins, Berson & Yalow (1962) found that some antisera discriminate widely between ox and human insulins whereas others show little discrimination.
The result of plotting C/ICi against i for an experiment with anti-(human insulin) serum, unlabelled human insulin and 131I-labelled ox insulin with method A is shown in Fig. 7 . In conformity with the principle of isotope dilution there is a linear relationship between CO/Ci and i, and CO/Ci is 1.0 when i is zero (statistical analysis showed no significant deviation from linearity). A similar type of relationship was observed in a further experiment (not shown) with anti-(ox-insulin) serum and unlabelled and I31I-labelled ox insulins. The linear relationship was observed under these conditions over a range of concentrations of unlabelled insulin from 5 to 320 microunits/ml.; at concentrations greater than 320 microunits/ml. the relationship ceased to be linear. In discussing the theoretical relationship for isotope dilution it was pointed out that this would only hold in relation to the immunoassay if the amount of insulin bound by antibody is independent of the concen- tration of insulin. This has been tested by studying the effect of increasing concentrations of 131I-labelled insulin (250-4000 ,tug. added in 0 1 ml.) on the recovery of radioactivity in the insulinantibody precipitate. The results of such an experiment with method A are shown in Fig. 8 . The radioactivity of the precipitate increased as the concentration of 1311-labelled insulin was increased and reached a plateau at a concentration of about 2000yjg. added in 0 1 ml. In the assay of insulin in human plasma it is necessary to limit the addition of 131I-labelled insulin to 250 ,u,g. in 0 1 ml., and it seems unlikely therefore that the theoretical relationship for isotope dilution will hold under these conditions. This does not, however, interfere with the use of the relationship between CO/Ci and i for the construction of a standard curve and such a linear relationship is a great advantage. This linear relationship has also been observed with methods B and C (see Fig. 11 ).
The effect of antisera to different insulins on the radioactivity of the insulin-antibody complex at different concentrations of unlabelled human insulin is shown in Fig. 9 . Method A was used and the experiments were made simultaneously with the same solutions of unlabelled human insulin and 131I-labelled ox insulin. The gradient of the reduction of radioactivity as a function of the concentration of unlabelled human insulin (plotted on a logarithmic scale) is much steeper with the anti-(human insulin) serum than with either anti-(ox insulin) or anti-(pig insulin) sera, particularly at the lowest insulin concentrations. This might suggest that the most sensitive assay of human insulin can 400r- be achieved with anti-(human insulin) serum. The relationship between CO/Ci and i for anti-(human insulin) and anti-(ox insulin) sera is shown in Fig. 10 , and though both relationships are linear the slope for anti-(human insulin) serum is much steeper than that for anti-(ox insulin) serum. A comparison between methods B and C is shown in Fig. 11 . In method C (in which the unlabelled human insulin is added 6 hr. before the 131I-labelled ox insulin) the reduction of the radioactivity of the insulin-antibody precipitate was greater at the lower concentrations of unlabelled human insulin than with method B, and, moreover, the slope of the reduction of radioactivity as a function of unlabelled insulin was greater in method C. Method C thus provides a more sensitive assay for insulin than method B. Assay of insulin in blood plasma. Each of these methods may be used to determine insulin in blood plasma provided that the standard insulin used is from the same species of animal (because of differences in reactivity of insulins from different species). In practice it is convenient to use a reference standard of ox insulin calibrated against human insulin (because of scarcity of the latter) in assaying insulin in human blood plasma. This has been done in many of the experiments described below.
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When plasma from five normal people was assayed for insulin with method A and with the use of a high concentration of precipitating antiserum (dilution less than 1:12), a satisfactory assay was achieved. The plasma insulin concentration was (in microunits/ml., given as means with the ranges in parentheses): after starvation, 16 (6-25); and 30, 60 and 150 min. after the oral administration of glucose (50 g.), 64 (35-88), 65 (43-120) and 22 (6-32) respectively. When five samples of human -plasma with high insulin activity were assayed at three dilutions (undiluted, and diluted 1: 2 and 1: 4) the calculated insulin contents at dilutions of 1:2 and 1:4 were (means ± s.E.M.) 105 ± 8-6 % and 87±18% of that of the undiluted samples (304 microunits/ml.). There was no significant difference between the estimates obtained from the three dilutions. The estimates of insulin concentrations in normal human plasma (see Table 1 ) are comparable Table 1 . Insulin concentration of plasma from normal people and from nonrmal or alloxan -diabetic rats Experimental details are given in the text. Human blood was collected from an antecubital vein, rat blood from the inferior vena cava under Nembutal anaesthesia. Values for rat plasma are given as equivalents of human insulin since standard rat insulin was not available.
Conen. of plasma insulin (microunits/ml.)
Source of blood plasma Yalow & Berson (1960) . When insulin was assayed in the same samples of plasma from five normal people with method A by using a low concentration of precipitating antiserum (1:32) a satisfactory assay was not achieved. The calculated insulin content was substantially higher (mean values: after starvation, 84 instead of 15 microunits/ml.; and 30, 60 and 150 min. after the oral administration of glucose, 170, 160 and 90 instead of 64, 65 and 21 microunits/ml. respectively; see Table 1 ). Moreover, when five samples of plasma were assayed undiluted, and diluted 1: 2 and 1:4, the calculated insulin concentrations at dilutions of 1: 2 and 1: 4 were 168 ± 15 % and 330 + 18-1 % respectively of that of undiluted plasma (equivalent to 150 microunits of human insulin/ml. of plasma). These observations showed that, at low concentrations of precipitating antiserum, dilution of human plasma did not lead to the expected fall in the insulin activity of the latter. It is suggested that this is due to interference by human y-globulin, which at low concentrations of rabbit anti-(guinea-pig y-globulin) serum (precipitating antiserum) removes enough of the latter by cross-reaction to render incomplete subsequent precipitation of the insulin-antibody complex. This leads to diminished radioactivity of the insulin-antibody precipitate and thereby to spuriously high values for plasma insulin activity, which, because of the high concentration of yglobulin, are not decreased by dilution of the plasma. In support of this idea it has been found that the complex between guinea-pig anti-(human insulin) serum and l3l1-labelled ox insulin can also be completely precipitated by anti-(human yglobulin) serum. Precipitation of human yglobulin and human plasma by rabbit anti-(guineapig y-globulin) serum has been demonstrated by immunodiffusion in agar gel.
The recovery of human insulin added to human plasma (by using method A and a high concentration of precipitating antiserum) was tested in three experiments. The recoveries of insulin (25, 50 and 100 microunits respectively) added to 1 ml. of plasma assayed to contain 41 microunits/ml. were 106, 99 and 113 %. Method A has also been applied to the assay of insulin in blood plasma collected from the inferior vena cava of fed normal and alloxan-diabetic rats (48 hr. after 60 mg. of alloxan/kg. had been given intravenously). In fed normal rats (mean plasma glucose concentration, 147 mg./100 ml.) the plasma insulin concentration (expressed as microunits of human insulin equivalent/ml.) was 130 ± 13 (mean + S.E.M. for four rats).
In plasma from five of six alloxan-diabetic rats (mean plasma glucose concentration, 1261 mg./ 100 ml.) no insulin could be detected (less than 6 microunits/ml. being the lower limit of the assay in this experiment). We conclude that method A can be used to assay insulin in plasma but that yglobulin can interfere if precipitating antiserum is not in excess.
Possible interference by y-globulin in plasma can be completely avoided if as in methods B and C the insulin antibody is first precipitated with precipitating antiserum and then used for the assay of insulin. Comnplete lack of interference by yglobulin is shown by the observation that the radioactivity of the precipitate is unaltered when 1311_ labelled insulin is added in undiluted guinea-pig serum instead of in phosphate buffer (insulin in guinea-pig serum does not react significantly because of the very low affinity of the antibody for guinea-pig insulin, as shown by using a sample of pure guinea-pig insulin provided by Dr L. F. Smith). With method C the mean insulin concentrations in samples of plasma from four normal people 30 min. after the oral administration of glucose (100 g.) were calculated to be 93, 112, 124 and 128 microunits/ml. when plasma samples were assayed undiluted and at dilutions of 1: 2, 1: 4 and 1: 8 respectively. These values are similar to those obtained with method A and by Yalow & Berson (1960) .
Sources of error. The accuracy with which a given concentration of insulin can be determined depends on the error associated with the experimental manipulations and assay of radioactivity and on the form and slope of the standard curve. The errors associated with the latter (assuming constant experimental error) are least when it is a straight line and when the slope is steepest.
The method of plating used (i.e. filtration through cellulose acetate membranes) gives the expected reproducibility in the assay of radioactivity of the precipitate as shown by repeated counts on a large number of samples. The error of the assay of radioactivity in the precipitate after duplicate sampling of an unknown insulin solution was about twice that of duplicate counting of single samples (the ratio of the standard errors was 2-05 for 14 pairs in each group). Experimental manipulations and counting thus contribute about equally to the overall error of the measured effect of a given concentration of insulin. Where great sensitivity is not required the accuracy may conveniently be enhanced by increasing the concentration of '31I-labelled insuhn and recording more counts. The ease of the manipulations involved in these methods also makes it practicable to perform a large number of replicate determinations and thereby to increase the accuracy. Since the counting error at a given total count is a fixed proportion of the count rate and since the lowest insulin concentrations are represented by the highest count rates, this error translated into units of insulin will be greatest at the lowest concentrations. To reduce this error a larger total of counts may be recorded on these samples. The error in determining the insulin concentration will be lowest where there is the greatest change in counts relative to change in insulin concentration and where the change in count rate represents a large proportion of the count rate. With methods A and B and the antiserum that we have used this appears to hold when the concentration of unlabelled insulin is 100-400 % of that of 13II-labelled insulin.
Since C0/Ci is linearly related to the concentration of unlabelled insulin over a reasonable range and COICi is a fixed point (1.0) when the latter is zero, the line can be most accurately fixed by measuring CO/Ci for a suitable concentration of insulin (see above) with an additional point to check the linearity of the relationship. Since the parameter of response, CO/Ci, is linearly related to dose, i, the relationship is similar to that of many microbiological assays and the Common Zero fivepoint assay design (two doses of standard, two of unknown and a common fixed point at zero dose) could be used with advantage (see Emmens, 1948) . By using this design and human insulin solutions with method A it has been calculated that the 95 % confidence limits with duplicate determinations on two doses of standard and two doses of unknown insulin solutions were + 15 % of the estimate.
The accuracy of this method can be conveniently compared with those of biological assay by calculating A (S.D. of points about the regression line divided by the slope of the regression line). This has been done for two standard curves obtained with method A by using the linear portion of a plot of radioactivity in the precipitate against log (insulin concentration) (since bioassays for insulin involve a semi-logarithmic plot). The calculated values for A were 0-056 and 0-016 as compared with 0-2 to 0-4 for rat-diaphragm bioassay (Randle, 1956 ) and 0-25 to 0-32 for rat-epididymal-fat-pad bioassay (Shepp et al. 1960) . The accuracy of the immunological method is thus superior to that of these biological assays.
General applkcability. The present studies were concerned with the use of the precipitation of insulin antibody for the assay of insulin. It seems reasonable to suggest that these methods would be applicable to the specific microassay of any protein which can be purified and labelled with a suitable radioactive isotope, which is antigenic and where precipitation of the antibody with anti-y-globulin serum does not interfere with the combination with antigen or vice versa. An assay for growth hormone involving some of these principles has been described by Utiger, Parker & Daughaday (1962) . These methods appear to be simpler and to be capable of achieving comparable sensitivity with that described by Yalow & Berson (1960) despite the use of radioactive insulin of much lower specific activity, and may thus be more readily applicable where the handling of large quantities of radioactive iodine presents difficulties. SUMMARY 1. Three new methods for immunoassay of insulin with guinea-pig anti-(human insulin) serum, 1311-labelled ox insulin and rabbit anti-yglobulin serum are described. In method A antiinsulin serum is used to obtain samples of insulin from solutions containing a fixed amount of 131k-labelled insulin mixed with standard or unknown solutions of unlabelled insulin, the insulin-antibody complex being precipitated with anti-y-globulin serum and the precipitate separated by filtration. Assay of radioactivity in the precipitate then permits the determination of insulin by reference to a standard curve. In method B insulin antibody is first precipitated with anti-y-globulin serum and the precipitate used to sample insulin mixtures. Method C is a modification of method B in which greater sensitivity is achieved by incubating the precipitated insulin antibody with unlabelled insulin before introducing the "3"I-labelled insulin.
2. Plasma y-globulin can interfere in method A if anti-y-globulin serum is not in excess but it cannot interfere in methods B or C. The latter are therefore preferred for the assay of insulin in blood plasma.
3. Methods A and B are in principle based on
